"Vitamin D" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.
| Descriptor ID |
D014807
|
| MeSH Number(s) |
D04.210.500.812.768
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Vitamin D".
Below are MeSH descriptors whose meaning is more specific than "Vitamin D".
This graph shows the total number of publications written about "Vitamin D" by people in this website by year, and whether "Vitamin D" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1997 | 1 | 1 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 0 | 1 | 1 |
| 2002 | 2 | 1 | 3 |
| 2003 | 2 | 1 | 3 |
| 2004 | 3 | 1 | 4 |
| 2005 | 2 | 1 | 3 |
| 2006 | 3 | 1 | 4 |
| 2007 | 3 | 4 | 7 |
| 2008 | 4 | 2 | 6 |
| 2009 | 2 | 3 | 5 |
| 2010 | 7 | 2 | 9 |
| 2011 | 3 | 4 | 7 |
| 2012 | 5 | 2 | 7 |
| 2013 | 8 | 4 | 12 |
| 2014 | 5 | 4 | 9 |
| 2015 | 13 | 3 | 16 |
| 2016 | 8 | 3 | 11 |
| 2017 | 8 | 2 | 10 |
| 2018 | 4 | 5 | 9 |
| 2019 | 5 | 3 | 8 |
| 2020 | 5 | 6 | 11 |
| 2021 | 1 | 2 | 3 |
| 2022 | 0 | 8 | 8 |
| 2023 | 0 | 2 | 2 |
| 2024 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitamin D" by people in Profiles.
-
Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies. Expert Opin Ther Targets. 2024 Aug; 28(8):669-687.
-
Serum parathormone, vitamin D and cardiovascular risk factors and markers: A pilot study. Nutr Metab Cardiovasc Dis. 2024 Oct; 34(10):2298-2304.
-
Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial. Adv Ther. 2024 Jun; 41(6):2500-2518.
-
Forgetting the Frail: National Trends in Vitamin D Prescription After Fragility Fracture-A Large Insurance Claims Database Study. J Am Acad Orthop Surg. 2024 May 15; 32(10):464-471.
-
Does the Doctor-Patient Relationship Affect Enrollment in Clinical Research? Acad Med. 2023 06 01; 98(6S):S17-S24.
-
Effectiveness of ocrelizumab on clinical and MRI outcome measures in multiple sclerosis across black and white cohorts: A single-center retrospective study. Mult Scler Relat Disord. 2023 Mar; 71:104523.
-
Efficacy and Safety of Parathyroid Hormone Replacement With TransCon PTH in Hypoparathyroidism: 26-Week Results From the Phase 3 PaTHway Trial. J Bone Miner Res. 2023 01; 38(1):14-25.
-
Association between vitamin D supplementation and COVID-19 infection and mortality. Sci Rep. 2022 11 12; 12(1):19397.
-
Management of Hypoparathyroidism. J Bone Miner Res. 2022 12; 37(12):2663-2677.
-
Effects of Vitamin D Supplementation on Adipose Tissue Inflammation and NF-?B/AMPK Activation in Obese Mice Fed a High-Fat Diet. Int J Mol Sci. 2022 Sep 18; 23(18).